Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug Administration (FDA) clearance for reprocessing the PentaRay Nav Eco High-Density mapping catheter manufactured by Biosense Webster. The PentaRay is a key medical device in atrial fibrillation (AF) procedures, one of the fastest growing and most expensive procedures in hospitals today, according to the company. Hospitals utilizing the reprocessed PentaRay and other expensive single-use labeled cardiology devices can save thousands of dollars on each AF procedure, potentially opening the procedure up for more patients.
FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by physician attendees for the Highlight of the year award in the interventional imaging category. This award celebrates promising technologies that will have the biggest impact in the field, on daily practice or on patients’ health and outlook. Cameron Dowling, M.D., St George’s, U.K., and Martin Swaans, M.D., Ph.D., St. Antonius, The Netherlands, shared their early experience with patient-specific computer simulation of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve morphology.
The new Post-Acute Care Heart Failure Certification offered from the American Heart Association (AHA) provides education and resources to skilled nursing facilities to reduce the hospital readmissions for heart failure patients.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
A study of a procedure developed at Henry Ford Health System shows inducing a heart attack in patients with heart disease could be a viable option for patients in need of mitral valve replacement.
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next generation of real-world research on behalf of cardiovascular disease and diabetes patients around the world.
Philips recently announced new advanced automation capabilities on its Epiq CVx and Epiq CVxi cardiac ultrasound systems. With Release 5.0, both systems now include automated applications for 2-D assessment of the heart, as well as robust 3-D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct.1 Together, the new applications provide clinicians with the means to confidently evaluate the heart’s function, increasing diagnostic confidence for patients with pulmonary hypertension, congenital heart disease, coronary disease and heart failure.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Judy Hung, M.D., director of echocardiography, Division of Cardiology, Massachusetts General Hospital, Boston, discusses ...
For patients at risk for sudden cardiac arrest (SCA) who are being evaluated for a permanent implantable cardioverter ...
DiA Imaging Analysis has partnered with Konica Minolta Healthcare Americas Inc. to expand analysis capabilities of Konica Minolta's Exa Cardio PACS platform (cardiovascular information system) with DiA's LVivo Toolbox for cardiac analysis.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 2, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
vRad (Virtual Radiologic), a Mednax company recently made a scientific presentation, “Screening for Aortic Dissection on CT Angiography Using a Convolutional Neural Network,” at the Society for Imaging Informatics in Medicine (SIIM) Annual Meeting, June 26-28 in Aurora, Colo.
Catheter Precision Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its new VIVO (View into Ventricular Onset) system for market release in the United States. VIVO is a pre-procedure planning tool that offers 3-D cardiac mapping to aid in localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to electrophysiology studies. The novel VIVO system uses magnetic resonance imaging (MRI) or a computed tomography (CT) scan along with a standard 12-lead ΕCG to computer-generate color-coded 3-D mapping images of the heart to indicate the area of earliest activation.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Biotronik announced the market release of its new injectable cardiac monitor (ICM), Biomonitor III, following approval in the CE region. The novel device is designed to help patients with irregular heart rhythms by documenting suspected arrhythmia or unexplained syncope with increased clarity.
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar ...
Partho Sengupta, M.D., MBBS, chief of cardiology, West Virginia Heart and Vascular Institute, explains how wearable ...